“Recombinant Deoxyribonucleoside Kinase from Drosophila Melanogaster Can Improve Gemcitabine Based Combined Gene Chemotherapy for Targeting Cancer Cells”. 2019. Biomolecules and Biomedicine 19 (4): 342-49. https://doi.org/10.17305/bjbms.2019.4136.